PENGARUH IMPLEMENTASI PHARMACEUTICAL CARE TERHADAP CAPAIAN KADAR FOSFAT DALAM DARAH PADA PASIEN HEMODIALISIS REGULER (Penelitian dilaksanakan di Rumah Sakit Adi Husada-Undaan Wetan Surabaya)
Background: Hyperphosphatemia is a disorder of mineral metabolism in chronic kidney disease particularly in hemodialysis (HD) patients. It is potentially life threatening by contributed to the development of mineral bone disease and cardiovascular calcification. Prevention of those prognosis thro...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses and Dissertations NonPeerReviewed |
| Language: | Indonesian Indonesian |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://repository.unair.ac.id/70564/1/TFK.%2014-18%20Fit%20p%20Abstrak.pdf http://repository.unair.ac.id/70564/2/TFK.%2014-18%20Fit%20p.pdf http://repository.unair.ac.id/70564/ http://lib.unair.ac.id |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | Indonesian Indonesian |
| Summary: | Background: Hyperphosphatemia is a disorder of mineral metabolism in chronic kidney
disease particularly in hemodialysis (HD) patients. It is potentially life threatening by
contributed to the development of mineral bone disease and cardiovascular calcification.
Prevention of those prognosis through multimodal therapy (diet restriction, used of
phosphate binder and hemodialysis) is essensial to decrease the morbidity and mortality
risk. Nevertheless, these managements have a low adherence level in Indonesia due to lack
of phosphate knowledge and pill burden. Therefore, implementation of pharmaceutical care
is required to overcome complicating factors and to improve the outcome therapy.
Objectives: To analyze the impact of pharmaceutical care on improving the achievement
phosphate, knowledge and adherence level and suppressing the amount of drug-related
problems (DRPs) in hemodialysis setting.
Methods: A single group pre and post test interventional study that conducted during 3
months. A total of 20 patients were enrolled at Adi Husada Undaan Wetan Surabaya
Hospital. Interventions given in the form of counseling, education and review therapy at
each patient visit.
Results: The intervention had a significant impact on phosphate levels (p < 0.05), knowledge
(p < 0.05) and DRP (p < 0.05) in the first follow-up, while adherence is not significant (p >
0.05). In the second follow-up, phosphate level was increase consequently the number of
patients who achieved the target decreased from 65% to 40%. Despite, other outcome was
still improved significantly (p < 0.05).
Conclusion: According to this study, implementation of pharmaceutical care in HD patients
showed improvement of knowledge and adherence level and reduction of DRP, meanwhile
there was no significant difference on phosphate serum levels because of cofounding factors
in hemodialysis processes and patient’s nutrition. |
|---|